Permeabilized germlings from the dimorphic fungus
INTRODUCTION
Protein kinase A (PKA) holoenzyme is an inactive tetramer composed of two monomeric catalytic subunits (C) bound to a dimer of regulatory subunits (R). The cooperative binding of two molecules of cAMP to each regulatory subunit decreases the affinity of the regulatory subunit for the catalytic subunit and promotes the activation of the holoenzyme. In vitro studies of the ligand regulation of PKA have demonstrated the cAMP dissociation of the holoenzyme by using nonequilibrium techniques. However, the in vivo activation of PKA has not been thoroughly studied, and there are some doubts regarding whether intracellular activation of PKA necessarily means dissociation. According to the dissociation constant of the mammalian holoenzyme with bound cAMP and the intracellular concentration of PKA (0.2 to 2 M [1]), cAMP-saturated PKA may exist within the cell without being dissociated into its subunits [2] . Work by Yang et al. [3] demonstrates that in vitro cAMP can induce holoenzyme activity without subunit dissociation and suggests that cAMP binding to PKA is insufficient to explain its in vivo dissociation.
Recent evidence suggests that signal transduction events are influenced by the assembly of multiprotein complexes composed of protein kinases, their effector molecules, and selected substrates [4] . At the core of these complexes are anchoring, adapter, or scaffold proteins, which provide a molecular framework upon which the signaling complexes are assembled [5] . PKAanchoring proteins (AKAPs) are prototypic examples of these signal-directing molecules, which sustain multicomponent signaling complexes of PKA and other enzymes [6] . The fact that PKA is not free within the cell but associated to multiprotein complexes suggests that it is possible that the mechanism of activation by cAMP within the cell is a complex process dependent on cAMP levels, and that it is different from what is observed in in vitro assays, where the cellular compartmentalization and localization of the kinase and anchoring proteins are disrupted.
We are particularly interested in understanding the intracellular activation of PKA. We have approached the study of the in vivo activation of PKA by studying the in vitro activation of PKA from the fungus Mucor rouxii at high, nonlinear holoenzyme concentration [7] in comparison with the behavior of the free C subunit and of the holoenzyme assayed under linear conditions.
We have concluded that the holoenzyme activation by cAMP under these conditions is highly dependent on the substrate. These results were interpreted as due either to the participation of the substrate in the activation of PKA by cAMP or to the existence of an active cAMP-bound holoenzyme with catalytic activity with kinetic parameters different from those of free C subunit.
We now approach the study of the in vivo activation of PKA using as a model its in situ activation in permeabilized M. rouxii cells. This procedure allows us to control the ionic and metabolic environment for the assay while preserving some of the in vivo intracellular compartments and the endogenous relationships between protein kinases, protein phosphatases, and their substrates. An important additional benefit of this approach is that the concentration of the proteins under study is maintained in normal intracellular values. We conclude that activation of PKA in situ has some exclusive properties, very different from those of the enzyme assayed in vitro at linear protein concentration, and with some similarity to those of holoenzyme in vitro at high, nonlinear concentrations.
MATERIALS AND METHODS
Cell growth. Fresh spores of Mucor rouxii (NRRL 1894) were produced and stored as previously described [8] . Aerobic cultures were grown to the germling stage for 5 to 6 h at 28°C under continuous shaking from a spore inoculum of 2ϫ 10 6 spores ml Ϫ1 in defined medium (DMG) consisting of mineral salt solution supplemented with vitamins [9] and 2% glucose. Cells were harvested by filtration and used immediately for permeabilization, for crude extract preparation, or for partial purification of PKA holoenzyme.
For microscopic observations, 4-ml cultures at 10 6 spores ml
Ϫ1
were grown in DMG with the addition of cAMP analogs, as indicated in each case, up to 16 h. Samples of cultures were withdrawn and observed under a light microscope. Morphologies were classified as follows: M, when cells germinated normally yielding a typical mycelium (Fig. 4A) ; P, when the effect on morphology was partial and the observed forms comprised round cells, cells with reduced hyphal branching, thicker hyphae with swollen tips, and forms consisting of rounded cells in a chain (Fig. 4B) ; and T, when the effect was total and the complete population consisted of rounded cells without buds (Fig. 4C) . About 100 cells were scored for each experiment. Permeabilization procedure. The permeabilization procedure was performed according to Serrano et al. [10] for Saccharomyces cerevisiae adapted and validated by Maggese et al. [11] for M. rouxii. A total of 1 to 2 ϫ 10 9 germling cells were suspended in 1 ml 40 mM Tris-HCl, pH 7.4, 0.5 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 3 g ml Ϫ1 antipain, 3 g ml Ϫ1 leupeptin, 1 mM benzamidine/ HCl, mixed with 0.15 ml toluene/ethanol (1:4 by vol), and vortexed for 2 min. The cells were immediately pelleted, washed once, and resuspended in the same buffer. Permeabilized cells were used within 30 min of preparation. More than 90% of the cells were permeabilized, as assessed by trypan blue (0.2%) exclusion.
Crude extract preparation. A measured number of germling cells (5 to 10 ϫ 10 7 cells) were submitted to disruption with glass beads at 4°C in 50 mM Tris-HCl, pH 7.4, 3 mM EGTA, 5 mM EDTA, 120 mM NaCl, 10 mM 2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 3 g ml Ϫ1 antipain, 3 g ml Ϫ1 leupeptin, and 1 mM benzamidine/HCl. Cell debris was pelleted by centrifugation for 5 min at 5000g and the supernatant was used immediately for enzymic assays in crude extracts. The total extract volume was carefully measured in order to make the final estimation of total PKA activity per cell. Protein in the extracts was measured by the Bradford assay.
Holoenzyme preparation. The holoenzyme was prepared from frozen germling powder. Extraction and enzyme purification through DEAE-Sepharose and sucrose gradient centrifugation were performed as described [12] . Partially purified preparations of the holoenzyme, at this stage of purification, were stored in aliquots at Ϫ20°C.
Protein kinase activity. Catalytic activity of PKA in vitro was determined by assay of its phophotransferase activity with kemptide or other specific peptides as substrates. The standard assay was started by mixing the samples (crude extract or partially purified PKA preparation) with assay mixture in a final volume of 70 l to give 50 mM Tris-HCl buffer, pH 7.4, 0.1 M NaCl, 0.2 mM [␥-32 P]ATP (500 to 700 cpm pmol Ϫ1 ), 0.5 mM EGTA, 0.1 mM EDTA, 15 mM MgCl 2 , 1 mM 2-mercaptoethanol, and the indicated concentrations of substrate and cAMP (when added). Routinely, kemptide was the substrate of choice and was used at 75 M. The use of other peptide substrates is indicated in the text. After 10 min at 30°C, aliquots were processed according to the phosphocellulose paper method [13] . Enzyme concentration was varied according to the experiments: crude extracts were used in the linear range of activity; partially purified preparations of PKA were either used at linear protein concentrations (conveniently diluted in homogenization buffer plus 0.5 mg ml Ϫ1 bovine serum albumin) or at nonlinear concentrations. Protein kinase assays were always linear with time.
PKA standard assay in situ was performed by incubation of samples containing 0.5 ϫ 10 6 to 1 ϫ 10 6 permeabilized cells in a final volume of 70 l for 2 min at 30°C in the incubation mixture described above, except for the use of 0.2 mM [␥-
32 P]-ATP of higher specific activity (1000 to 1200 cpm pmol Ϫ1 ). The reaction was stopped by addition of 5 l bovine serum albumin 50 mg ml Ϫ1 and boiling for 45 s; after a brief spin, aliquots of the supernatant were processed according to the phosphocellulose paper method [13] . The optimum conditions for the standard assay were obtained after a systematic variation in each of the critical parameters, namely number of cells, incubation time, and concentration of ATP, Mg 2ϩ , kemptide, and cAMP (data not shown).
One unit of protein kinase activity is defined as 1 pmol of phosphate incorporated into kemptide (or peptide substrate) per minute under the standard assay conditions. cAMP binding assay. Holoenzyme concentration was estimated by cAMP binding, taking into account that four molecules of cAMP bind per molecule of holoenzyme. cAMP binding was measured by the nitrocellulose filter assay. The enzyme sample (crude extract or partially purified PKA preparation) was incubated with the assay mixture in a final volume of 100 l for 20 min at 30°C. Final concentrations in the assay were 50 mM Tris-HCl buffer, pH 7.4, 0.5 M NaCl, and 1 M [ 3 H]cAMP. An aliquot was spotted on nitrocellulose membrane filters under vacuum and immediately washed with 10 ml cold Tris-HCl buffer, pH 7.4.
Materials.
[␥ 32 P]ATP and [ 3 H]cAMP were purchased from New England Nuclear. Phosphocellulose P-81 paper was purchased from Whatman. Kemptide and cAMP analogs were purchased from Sigma Chemical Co. Peptide substrates, besides kemptide, were provided by Dr. Lorenzo Pinna's laboratory (Universidy of Padua, Italy). All other reagents were of analytical grade.
RESULTS AND DISCUSSION

Properties of the PKA Assay in Permeabilized Cells
Cells from the germling stage of M. rouxii growth curve were chosen to permeabilize in order to assay PKA activity in situ. At this stage of growth, cells are suitable for permeation (at later, mycelial, stages they are not), and the specific activity of both C and R subunits has almost reached the levels of midlog growth cultures [14] . The PKA assay in permeabilized cells was optimized regarding cell number, incubation time, ATP, Mg 2ϩ , kemptide, and cAMP concentration in order to have the best measure of the total activity of PKA in these cells (data not shown).
We were interested in comparing the total protein kinase activity per cell obtained from measurements in permeabilized cells with those derived from in vitro assays in crude extracts obtained from a known number of cells from the same batch. Optimal incubation conditions were settled for both assays. Figures 1A and  1B show the profile of PKA activity vs increasing number of cells in situ (Fig. 1A) and crude extract protein in vitro (Fig. 1B) . Figure 1C shows that the total activity of PKA, expressed per 10 6 cells, is around sevenfold greater when estimated from the in vitro assay of crude extracts than from the in situ assay using permeabilized cells. Both activities, in vitro and in situ (see Fig.  2A ), are absolutely dependent on kemptide and on the addition of cAMP, indicating that in both cases, the kemptide phosphorylating activity can be attributed to PKA.
This difference between activity estimated from in situ assays and the in vitro estimations suggests that not all the PKA activity within the cell can be activated in the in situ assay. From previous reports from our group [7, 15] we know that activation of PKA in vitro, in the region where the activity vs protein begins to deviate from linearity, can be stimulated by addition of 0.5 M NaCl or by polycations, two agents known to promote dissociation of M. rouxii PKA subunits together with cAMP [16] . In order to test whether we could unshield more PKA activity by the addition of these dissociation-promoting agents, we assayed the phosphorylation of kemptide in situ in the presence of cAMP 10 M together with either a mixture of 1 mM spermidine plus 1 mM spermine, or with 0.5 M NaCl. The results (not shown) indicate that the activity plus cAMP could be increased around 2.5-fold by the addition of the polyamine mixture and around 2-fold by addition of 0.5 M NaCl, and that this stimulating effect was absolutely cAMP dependent. Adequate controls for the effect of polyamines and of NaCl on the catalytic reaction itself can not be settled in permeabilized cells. However, we have shown that in vitro, the catalytic activity of free C subunit toward kemptide is slighlty stimulated (1.3-to 1.4-fold) by the mixture of polyamines [15] and strongly inhibited by high ionic strength [16] ; therefore, it is possible that the degree of stimulation observed in situ could be overestimated in the case of polyamine addition and underestimated when assayed in the presence of 0.5M NaCl. These results suggest that the increase in PKA activity promoted by polycations and high salt, together with cAMP, could be the result of a decrease in ionic interactions between both subunits of the holoenzyme or between PKA and other proteins.
In Situ PKA Activity Assayed with Different Peptide Substrates
From previous experiments from our group, we know that the apparent in vitro PKA relative specific activity toward different peptide substrates depends on the holoenzyme concentration in the assay [7] . At lowlinear concentrations of PKA (in the subnanomolar range), the observed relative specific activity using different peptide substrates, measured at high cAMP concentration (100 M), was identical to the one displayed by the free C subunit, as expected for a complete dissociation of the holoenzyme. However, at high, nonlinear concentrations of enzyme (in the nM range), the relative apparent specific activity with several peptide substrates was completely different. We were inter- ested in analyzing the behavior of PKA to activation by cAMP in situ when using different peptide substrates. Four peptides were selected-kemptide (K), RRASVA (R2), RRRRASVA (R4), and KRRRLSSLRA (S6)-and used at a concentration threefold higher than their respective K m values (determined in vitro using free C subunit [7] ). Figure 2A shows the results of such an experiment. The first observation is that the phosphorylation of the different peptide substrates is absolutely (kemptide and R2) or highly (R4 and S6) dependent on the addition of exogenous cAMP, suggesting that their phosphorylation can be attributed to PKA. An important observation is that the relative activity of PKA toward the different substrates is different from the efficiency displayed by the isolated C subunit in vitro ( Fig. 2B ; [4] ). The difference in efficiency of phosphorylation parallels the behavior of the fungal enzyme in vitro at high enzyme concentrations [4] . The relative activity of the kinase toward the different substrates seems to attain saturation in the cAMP effect in the range of concentrations of cAMP shown, except for R2, which is saturated by cAMP from 50 M onward (data not shown). These results suggest that within the cell, the PKA in the presence of cAMP does not display the same behavior of free C subunit in vitro.
A surprising result of this experiment is that a clear saturation curve for cAMP is observed for three of the four substrates, with an A 0.5 for cAMP around 1 M or less. With kemptide as a substrate, the maximal activity attained is much lower than the maximal PKA activity obtained from the same amount of cells, measured in vitro in the crude extracts (Fig. 1C) . This result is interesting because it differs completely from the behavior of the PKA in vitro at high enzyme concentrations, even though the concentration of PKA within the cell is higher than the highest concentrations used in the in vitro assays (100 -200 nM [13] vs 3 nM [7] ). Under in vitro conditions (see fig. 2 of [7] ), PKA activity assayed with the different substrates increased very slowly every time the cAMP concentration was increased 10-fold from 0.1 to 1000 M, and even at the highest concentration of cAMP, a saturation effect was not observed and the theoretically maximal activity was far from being attained.
Activation of PKA with cAMP Analogs in Situ vs in Vitro
The R subunit of protein kinase A has two cAMP binding sites, A and B, to which cAMP binds cooperatively during holoenzyme activation. N 6 -substituted cAMP analogs are selective for cAMP binding site A, while C-8 -substituted cAMP analogs are site B selective [16] . The fungal enzyme has been demonstrated to display the same site selectivity for cAMP analogs of mammalian enzymes [12] . We were interested in comparing the behavior of the holoenzyme in in situ and in vitro assays toward representative cAMP analogs from both groups of site selectivity. The analogs selected were N 6 -benzoyl-cAMP, N 6 -monobutyryl-cAMP, 8-benzylamino-cAMP, and 8-bromo-cAMP. Figure 3 shows the activation curves of PKA with the different cAMP analogs, with kemptide as a substrate, in vitro at two enzyme concentrations (0.1 and 1 nM; Fig. 3A and Fig.  3B , respectively) and in situ (Fig. 3C) .
The results show that in vitro an increase in holoenzyme concentration is accompanied by an increase in the concentration of analogs needed to promote the same degree of activation (Figs. 3A, 3B ). This phenomenon was expected since it is already known to occur regarding activation by cAMP or its analogs. In the case of Fig. 3B , at high enzyme concentration, maximal activation is not attained if one estimates the expected amount of PKA activity from the data of Fig. 3A , in which 10-fold less enzyme is being used. However, in
FIG. 2. (A)
In situ measurement of PKA activity with four exogenous peptide substrates. PKA assays were performed under the standard assay conditions except for the substrates that were used at the following concentrations: 150 M kemptide, 120 M R2, 15 M R4, 45 M S6, and cAMP, which was varied from 0 to 50 M. Data points are the mean of triplicate determinations (ϮSD). A representative experiment of five is shown. (B) The specific activity of protein kinase assayed in situ with each substrate at saturating cAMP concentration (minus the activity in the absence of cAMP) was expressed relative to the activity obtained with R2 (taken as 1); data were obtained from in situ assays of five independent experiments, such as the one shown in A (ϮSEM). The data for free C subunit in vitro were obtained from our own results (reported in [7] ), redrawn to simplify the comparison. 14] , much higher than the concentration used in vitro, the concentration of N 6 -analogs necessary to promote activation does not increase accordingly, a phenomenon similar to the one observed when using cAMP (see Fig. 2 ). The most important result from these experiments is the difference in activation potency displayed by the cAMP analogs at high enzyme concentration or in permeabilized cells. The two site A-selective analogs behave as good activators, while the site B-selective analogs activate very poorly. At low concentration of analogs, even at low enzyme concentration (Fig. 3A) , there is already a slight preference for site A-selective analogs for activation potency.
In Vivo Behavior of Site-Selective cAMP Analogs
We have a good assay with which to test the behavior of the site-selective cAMP analogs in vivo, and this is the effect cAMP analogs have on polarized aerobic growth of the fungal spores when added to the culture medium [18, 19] . The addition of either dibutyrylcAMP (not shown) or N 6 -cAMP analogs promotes the impairment of polarized growth, and cells grow isodiametrically (Figs. 4A, 4C) ; at concentrations of the compounds where the effect is not total, a partial effect is clearly observed with severe abnormalities in the mor- Table 1 . (B, C) Partial and total effects observed at 16 h of growth with different additions (see Table 1 ; morphologies indicated as P and T, respectively). Bar, 28 m. phology (Fig. 4B) . In every case, the effect of the analogs does not impair cell growth [18] . Table 1 shows that N 6 -cAMP analogs produced the effect on morphology, while the two C8-cAMP analogs tested, up to 1 or 3 mM, did not produce even a partial effect. We do not think this difference is due to differences in the degree of permeability of the compounds, since reported data for hydrophobicity [20, 21] (Table 1) do not correlate with the effect on morphology. A suitable explanation for the different effect on morphology of the two types of analogs may be found on the difference in PKA activation in vivo, as reflected by the in situ assay (Fig.  3C) and not by the in vitro assay at low enzyme concentration (Fig. 3A) .
CONCLUSIONS
In general, when the catalytic properties of an enzyme is studied in vitro, the concentration of enzyme used is such that there exists a linear relationship between the activity and enzyme concentration. It is from those data that predictions of the behavior of the enzyme in vivo are made. However, when we compare the properties of M. rouxii PKA measured in situ with data obtained from low concentrations of the fungal enzyme PKA in vitro, we find some important differences: (1) the apparent specific activity of the PKA (expressed in units/cell) toward kemptide is much lower in situ (Fig. 1) ; (2) the relative specific activity of PKA towards the phosphorylation of four peptide substrates (kemptide, R2, R4, and S6) measured in situ differs from the data obtained with free C (Fig. 2; [4] ); (3) N 6 -cAMP analogs are very good activators of PKA in situ and C8-cAMP analogs are very poor activators (Fig. 3C) , while in vitro at low enzyme concentration (Fig. 3A) , both type of analogs are almost equally potent.
Comparison of the properties of PKA from the in situ assay differ also from those of PKA in vitro at high enzyme concentration. Although the behavior toward the peptide substrates ( Fig. 2; [4] ) and the difference in activation potency of the site-selective cAMP analogs (Fig. 3) are quite similar, there is an important difference in the concentration of cAMP that promotes maximal activation in permeabilized cells. From the results of holoenzyme at high, nonlinear concentrations, one would have predicted that a high concentration of cAMP would be needed to activate the high intracellular concentration of PKA. However, this is not the case, and concentrations of cAMP in the micromolar range are sufficient to maximally activate the enzyme within the cell.
We can posit possible interpretations to explain some of the results observed with permeabilized cells, namely, difference in the total activity per cell and in the relative activity toward peptide substrates: (1) saturation in the cAMP response curve indicates that only a pool of PKA is available for activation by cAMP in the in situ assay; this interpretation might fit with the lower total activity observed when using kemptide as substrate as compared with the kemptide kinase activity in crude extracts; however, it does not explain the difference in efficiency of PKA to the different substrates within the cell; and (2) saturation in the cAMP response curve indicates that complete activation of all the PKA within the cell is attained; therefore, in order to explain the difference in specific activity of PKA toward the different substrates as compared with free C subunit (in vitro) and the difference in the total kemptide activity when compared to the one measured in crude extracts, it has to be supposed that the phosphorylating species within the cell has a different catalytic efficiency than isolated C subunit in vitro.
The high performance of cAMP and of N 6 -cAMP analogs in the activation of the holoenzyme in situ compared with the concentrations needed to activate nonlinear concentrations of PKA in vitro can be interpreted to be due to interaction with other proteins within the cell. Even though formal AKAPs have not been described in lower eukaryotes, a recent work reports the localization of the R subunit of PKA in Saccharomyces cerevisiae through the interaction with the protein Zds1 [22] . On the other hand, a complex scaffold has been demonstrated in yeast to be involved in the signal transduction, linking all the components of the MAPK pathway [23] . One is tempted to speculate c Partition coefficient obtained from Beebe et al. [20] . d Retention data in a reversed-phase high-performance liquid chromatography obtained from Braunmann et al. [21] .
that even in lower eukaryotes, PKA is immersed in a macromolecular complex through a chain of proteinprotein interactions and that in this position, it is very susceptible to efficient activation by cAMP, resembling somehow the efficiency of an intramolecular autophosphorylation process, in which both the enzyme and the target substrate belong to the same molecule (or same multiprotein complex, in this case).
We think that the study of PKA in situ is a better model to predict or study the in vivo activation of PKA. One example is the good correlation observed between the potency of the site-selective analogs in situ in the activation of PKA and in vivo in the effect upon cell morphology. We have already successfully applied this approach to evaluate the in vivo activation of PKA in S. cerevisiae [24] .
